At Teva, our pioneering mindset – in both ambition and commitment - aims to develop treatments that can enhance care and improve patients’ quality of life, and meet the needs of healthcare providers.
Teva focuses on innovative medicine for various therapeutic areas including neuroscience and immunology for non- and rare diseases, tackling some of the world’s most pressing health challenges.
In neuroscience, we target several debilitating movement disorders, severe and enduring mental health conditions, and migraine pain, including Huntington’s disease chorea, tardive dyskinesia (TD), schizophrenia, multiple system atrophy (MSA) and Parkinson’s disease (PD).
We focus on innovative treatments for movement disorders to enhance patients' quality of life and aid in chronic disease management.
We focus on solutions supporting patients coping with chronic and episodic migraine, to help them regain control of their daily activities.
Our neuroscience research tackles severe and enduring mental health conditions, focused on bringing innovative solutions where there is unmet need.
In immunology, we focus on a range of therapeutic areas including gastroenterology, respiratory medicine, dermatology and immuno-oncology. Overall, our efforts include developing treatments for inflammatory bowel disease, asthma, celiac disease, vitiligo and more. In immuno-oncology alone, we’re exploring new ways to harness the body’s immune system to fight multiple cancers like malignant melanoma, offering hope to patients with challenging immune-based diagnoses and unmet medical needs.
Our efforts in immunology examine various treatments that improve lung function and overall respiratory health.
We are exploring ways to harness the immune system to fight challenging immune-based diagnoses and unmet medical needs.
More details will be added soon.
Teva is committed to making a difference in the lives of patients through innovation and scientific excellence. We leverage our in-depth therapeutic area expertise and extensive research capabilities to collaborate with leading academic institutions, healthcare organizations, and industry partners to drive innovation and bring new, much needed, treatments to market.
We invite you to learn more about Teva’s innovative therapeutic areas and our efforts to bring new and effective treatments to patients around the world.
NPS-ALL-NP-01528 APRIL 2025